咨询与建议
  • 全部检索
  • 电子图书
  • 电子期刊
  • 纸本馆藏
  • 南通市公共图书馆
高级检索

限定检索结果

文献类型

  • 3 篇 期刊文献

馆藏范围

  • 3 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 3 篇 医学
    • 3 篇 临床医学

主题

  • 1 篇 荟萃分析
  • 1 篇 恶性腹腔积液
  • 1 篇 重组人血管内皮抑...
  • 1 篇 chemotherapy
  • 1 篇 血管新生
  • 1 篇 drugs
  • 1 篇 晚期转移性胰腺癌
  • 1 篇 吉西他滨
  • 1 篇 肿瘤
  • 1 篇 folfiri
  • 1 篇 白蛋白结合型紫杉...

机构

  • 1 篇 department of me...
  • 1 篇 department of me...
  • 1 篇 department of ra...
  • 1 篇 department of ab...
  • 1 篇 department of ga...
  • 1 篇 department of on...
  • 1 篇 department of me...
  • 1 篇 department of me...
  • 1 篇 department of me...
  • 1 篇 department of me...
  • 1 篇 department of me...
  • 1 篇 department of me...
  • 1 篇 department of me...
  • 1 篇 department of me...
  • 1 篇 department of me...
  • 1 篇 department of ga...
  • 1 篇 department of me...
  • 1 篇 department of me...
  • 1 篇 department of ab...
  • 1 篇 department of me...

作者

  • 2 篇 秦叔逵
  • 1 篇 huafang su
  • 1 篇 lin shen
  • 1 篇 kangsheng gu
  • 1 篇 yong fang
  • 1 篇 xiaofeng li
  • 1 篇 xiaohua hu
  • 1 篇 baoli qin
  • 1 篇 jun liang
  • 1 篇 wenling wang
  • 1 篇 zishu wang
  • 1 篇 jianwei yang
  • 1 篇 刘秀峰
  • 1 篇 xianli yin
  • 1 篇 jianping xiong
  • 1 篇 zemin xiao
  • 1 篇 weixian liu
  • 1 篇 liangjun zhu
  • 1 篇 yiye wan
  • 1 篇 魏蕾

语言

  • 2 篇 中文
  • 1 篇 英文
检索条件"作者=Shuqui qin"
共 3 条 记 录，以下是1-10 订阅
全选 清除本页 清除全部 题录导出 标记到"检索档案"
详细 简洁
排序：
SALIRI-based(raltitrexed plus irinotecan)therapy as a second-line treatment for patients with metastatic colorectal cancer(SALLY):A prospective,multicenter,non-interventional,registry study
收藏
分享
引用
Cancer Communications 2024年 第8期44卷 910-914页
作者： shuqui qin Jin Li Aiping Zhou Yanqiao Zhang Xianglin Yuan Liangjun Zhu Baoli qin Shan Zeng Lin Shen Ying Yuan Weibo Wang Jun Liang Xianwen Zhang Feng Ye Ping Chen HuaizhangWang Zhenyan Yu Lu Yue Yong Fang Jianping Xiong Jianwei Yang Yiye Wan Xianli Yin Wenling Wang Nong Xu XiaohongWang Zemin Xiao Huafang Su YingWang Kangsheng Gu Shuiping Tu Zishu Wang Bo Liu Xiaohua Hu Weixian Liu Xiaofeng Li Department of Oncology Nanjing Tianyinshan HospitalNanjingJiangsuP.R.China Department of Medical Oncology Shanghai East HospitalShanghaiP.R.China Department of Medical Oncology Cancer Hospital Chinese Academy of Medical SciencesBeijingP.R.China Department of Gastroenterology Harbin Medical University Cancer HospitalHarbinHeilongjiangP.R.China Department of Medical Oncology Tongji HospitalTongji Medical CollegeHuazhong University of Science and TechnologyWuhanHubeiP.R.China Department of Medical Oncology Jiangsu Cancer HospitalNanjingJiangsuP.R.China Department of Gastroenterology Liaoning Cancer Hospital&InstituteShenyangLiaoningP.R.China Department of Oncology Xiangya HospitalCentral South UniversityChangshaHunanP.R.China Department of Medical Oncology Beijing Cancer HospitalBeijingP.R.China Department of Medical Oncology The Second Affiliated HospitalZhejiang University School of MedicineHangzhouZhejiangP.R.China Department of Chemotherapy Shandong Provincial HospitalJinanShandongP.R.China Department of Medical Oncology Peking University International HospitalBeijingP.R.China Department of Medical Oncology Northern Jiangsu People’s HospitalYangzhouJiangsuP.R.China Department of Medical Oncology The First Affiliated Hospital of Xiamen UniversityXiamenFujianP.R.China Department of Medical Oncology General Hospital of NingxiaMedical UniversityYinchuanNingxiaP.R.China Department of Integrated Chinese andWestern Medicine Henan Cancer HospitalZhengzhouHenanP.R.China Department of Medical Oncology Mudanjiang Tumor HospitalMudanjiangHeilongjiangP.R.China Department of Oncology Qingdao Municipal Hospital(Group)QingdaoShandongP.R.China Department of Medical Oncology Sir Run Run Shaw HospitalZhejiang University School of MedicineHangzhouZhejiangP.R.China Department of Medical Oncology The First Affiliated Hospital of Nanchang UniversityNanchangJiangxiP.R.China Department of Abdominal Oncology Fujian Cancer HospitalFuzhouFujianP.R.China Department of Gastroent
Primary chemotherapy options for colorectal cancer(CRC)involve four key drugs:fluorouracils(5-FU),oxaliplatin,irinotecan and *** first-line regimen consists of 5-FU and leucovorin combined with oxaliplatin(FOLFOX),whi... 详细信息
来源： 维普期刊数据库 维普期刊数据库 评论
重组人血管内皮抑制素腔内注射治疗恶性腹腔积液的研究进展
收藏
分享
引用
临床肿瘤学杂志 2019年 第9期24卷 856-861页
作者： 晁娇娇 秦叔逵 南京中医药大学研究生院 南京2100023 解放军东部战区总医院(原八一医院)全军肿瘤中心 210002
恶性腹腔积液(MA)是指由于恶性肿瘤局部侵犯腹膜或转移引起液体在腹膜腔内的病理性聚积。MA是晚期恶性肿瘤常见的并发症之一,患者预后往往较差,临床上尚缺乏公认的标准治疗药物和方案。MA的形成与原发肿瘤类型和位置存在相关性。当前MA... 详细信息
来源： 维普期刊数据库 维普期刊数据库 同方期刊数据库 同方期刊数据库 评论
吉西他滨单药或联合白蛋白结合型紫杉醇治疗东亚人群晚期胰腺癌临床疗效的荟萃分析
收藏
分享
引用
临床肿瘤学杂志 2019年 第2期24卷 137-144页
作者： 魏蕾 李自雄 秦叔逵 刘秀峰 南京中医药大学附属八一医院全军肿瘤中心肿瘤内科 南京210002
目的系统评价吉西他滨单药和吉西他滨联合白蛋白结合型紫杉醇一线治疗东亚人群晚期转移性胰腺癌的疗效,以期为中国转移性胰腺癌临床一线治疗的合理用药提供依据。方法按照预设的纳入和排除标准,在万方、Cochran Library、MEDLINE、PubMe... 详细信息
来源： 维普期刊数据库 维普期刊数据库 同方期刊数据库 同方期刊数据库 评论
全选 清除本页 清除全部 题录导出 标记到“检索档案”
共1页 <<  < 1 >  >>
回到顶部
执行限定条件